1. Home
  2. ARLO vs LBRX Comparison

ARLO vs LBRX Comparison

Compare ARLO & LBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arlo Technologies Inc.

ARLO

Arlo Technologies Inc.

N/A

Current Price

$12.36

Market Cap

1.4B

ML Signal

N/A

Logo LB Pharmaceuticals Inc

LBRX

LB Pharmaceuticals Inc

N/A

Current Price

$37.11

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ARLO
LBRX
Founded
2018
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
2018
2025

Fundamental Metrics

Financial Performance
Metric
ARLO
LBRX
Price
$12.36
$37.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
10
Target Price
$21.00
★ $57.30
AVG Volume (30 Days)
★ 1.2M
337.4K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 145.16
98.22
EPS
★ 0.16
N/A
Revenue
N/A
N/A
Revenue This Year
$11.76
N/A
Revenue Next Year
$5.56
N/A
P/E Ratio
$75.94
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.05
$14.32
52 Week High
$19.94
$50.16

Technical Indicators

Market Signals
Indicator
ARLO
LBRX
Relative Strength Index (RSI) 41.80 40.51
Support Level $12.23 $26.75
Resistance Level $14.01 $49.74
Average True Range (ATR) 0.47 2.09
MACD -0.06 -0.27
Stochastic Oscillator 32.87 37.63

Price Performance

Historical Comparison
ARLO
LBRX

About ARLO Arlo Technologies Inc.

Arlo Technologies Inc is engaged in the provision of security and video monitoring solutions for homes and businesses. Its cloud-based platform provides users with visibility, insight, and a powerful means to help protect and connect in real-time with the people and things that matter, from any location with a Wi-Fi or cellular connection. The company offers subscription services such as Arlo Secure, Arlo Total Security, and Arlo Safe, and several categories of smart security devices, including smart Wi-Fi and LTE-enabled cameras, video doorbells, floodlight cameras, and home security systems. Geographically, the company generates a majority of its revenue from the United States, followed by Spain, Sweden, and other countries.

About LBRX LB Pharmaceuticals Inc

LB Pharmaceuticals Inc is a late-stage biopharmaceutical company developing novel therapies for the treatment of a wide range of neuropsychiatric disorders including schizophrenia, bipolar depression, adjunctive treatment of depressive disorder and other diseases. It is building a pipeline that leverages the broad therapeutic potential of its product candidate, LB-102, which it believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is currently in late-stage clinical development for schizophrenia and bipolar depression. The company operates as a single reportable segment in the development of novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia.

Share on Social Networks: